Sara Bonstein [Image courtesy of Insmed]
In January 2020, rare disease biopharma Insmed (Nasdaq: INSM) hired Sara Bonstein as its chief financial officer. At that point, Bonstein had more than 15 years of operational and financial experience in the life sciences industry.In the following interview highlighting her role as a female pharma leader, Bonstein shares what initially attracted her to drug discovery and development and which projects at Insmed she finds most rewarding. She also provides perspective on leadership skills and what the industry can do to promote greater participation of young women in the pharma industry — especially in senior finance roles.
What first drew you to drug discovery and development? When did you first know you wanted to be in the industry?Bonstein: During my freshman and sophomore years of college, Johnson & Johnson was recruiting on campus and I went to the informa…